GlassScriptPhysician profile
Caitlin M Brazda
NPI 1225474174
$2,119.13
in general payments reported to CMS, 2019-2025
17 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $103 · 2021: $62.87 · 2022: $145 · 2023: $466 · 2024: $478 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.29 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $435.17 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $421.72 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $254.11 | 2019-2023 | Acessa Provu System, Novasure, Coolseal Generator |
| Minerva Surgical, INC | $238.51 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $150.93 | 2023-2024 | Myfembree, Gemtesa |
| Lupin INC. | $136.61 | 2019-2020 | |
| Biogen, INC. | $120.61 | 2024-2025 | Zurzuvae |
| Myriad Women'S Health, INC. | $63.19 | 2023 | Myrisk |
| Daiichi Sankyo INC. | $55.74 | 2019-2023 | Injectafer |
| Roche Diagnostics Corporation | $46.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.06 | 2023-2025 | |
| Exeltis, USA INC. | $39.27 | 2023-2025 | Slynd |
| Organon LLC | $33.28 | 2024 | |
| Pfizer INC. | $30.76 | 2022-2024 | |
| Boston Scientific Corporation | $24.82 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $16.94 | 2024 | Ova1 |
| Amag Pharmaceuticals, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Brazda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.